China Guillain-Barré Syndrome Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Guillain-Barré Syndrome industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Nihon Pharmaceutical

    • Akari Therapeutics

    • CSL Behring

    • Kedrion

    • Biotest

    • Grifols

    • China Biologic Products Holdings

    By Type:

    • LMWH

    • Plasma Exchange

    • Anticonvulsants

    • Analgesics

    • Intravenous Immunoglobulin

    By Application:

    • Home Care

    • Clinics

    • Retail Pharmacies

    • Hospital Pharmacies

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Guillain-Barré Syndrome Market Overview 2018-2029

    • 1.1 China Guillain-Barré Syndrome Industry Development Overview

    • 1.2 China Guillain-Barré Syndrome Industry Development History

    • 1.3 China Guillain-Barré Syndrome Industry Market Size (2018-2029)

    • 1.4 China Guillain-Barré Syndrome Market Analysis by Type from Production Side

      • 1.4.1 China Guillain-Barré Syndrome Production Volume, Production Value and Growth Rate of LMWH (2018-2029)

      • 1.4.2 China Guillain-Barré Syndrome Production Volume, Production Value and Growth Rate of Plasma Exchange (2018-2029)

      • 1.4.3 China Guillain-Barré Syndrome Production Volume, Production Value and Growth Rate of Anticonvulsants (2018-2029)

      • 1.4.4 China Guillain-Barré Syndrome Production Volume, Production Value and Growth Rate of Analgesics (2018-2029)

      • 1.4.5 China Guillain-Barré Syndrome Production Volume, Production Value and Growth Rate of Intravenous Immunoglobulin (2018-2029)

    • 1.5 China Guillain-Barré Syndrome Market Analysis by Application from Consumption End

      • 1.5.1 China Guillain-Barré Syndrome Sales Volume, Sales Value and Growth Rate of Home Care (2018-2029)

      • 1.5.2 China Guillain-Barré Syndrome Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

      • 1.5.3 China Guillain-Barré Syndrome Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)

      • 1.5.4 China Guillain-Barré Syndrome Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)

    • 1.6 China Guillain-Barré Syndrome Market Analysis by Region

      • 1.6.1 North China Guillain-Barré Syndrome Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Guillain-Barré Syndrome Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Guillain-Barré Syndrome Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Guillain-Barré Syndrome Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Guillain-Barré Syndrome Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Guillain-Barré Syndrome Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Guillain-Barré Syndrome Market Size and Growth Rate from 2018-2029

    Chapter 2 China Guillain-Barré Syndrome Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Guillain-Barré Syndrome Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Guillain-Barré Syndrome Market Status and Competition Analysis in 2023

      • 2.2.3 China Guillain-Barré Syndrome Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Guillain-Barré Syndrome Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Guillain-Barré Syndrome Industry Development

    Chapter 3 Guillain-Barré SyndromeIndustry Chain Analysis

    • 3.1 Guillain-Barré Syndrome Industry Chain

    • 3.2 Guillain-Barré Syndrome Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Guillain-Barré Syndrome Market

    • 3.3 Guillain-Barré Syndrome Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Guillain-Barré Syndrome Market

    Chapter 4 China Guillain-Barré Syndrome Market, by Type

    • 4.1 China Guillain-Barré Syndrome Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Guillain-Barré Syndrome Total Production Volume and Growth Rate from Production Side

    • 4.5 China Guillain-Barré Syndrome Production Volume and Growth Rate, by Type

      • 4.5.1 China Guillain-Barré Syndrome Production Volume and Growth Rate of LMWH

      • 4.5.2 China Guillain-Barré Syndrome Production Volume and Growth Rate of Plasma Exchange

      • 4.5.3 China Guillain-Barré Syndrome Production Volume and Growth Rate of Anticonvulsants

      • 4.5.4 China Guillain-Barré Syndrome Production Volume and Growth Rate of Analgesics

      • 4.5.5 China Guillain-Barré Syndrome Production Volume and Growth Rate of Intravenous Immunoglobulin

    Chapter 5 China Guillain-Barré Syndrome Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Guillain-Barré Syndrome Total Market Size and Growth Rate from Consumption End

    • 5.5 China Guillain-Barré Syndrome Market Size and Growth Rate, by Application

      • 5.5.1 China Guillain-Barré Syndrome Market Size and Growth Rate of Home Care

      • 5.5.2 China Guillain-Barré Syndrome Market Size and Growth Rate of Clinics

      • 5.5.3 China Guillain-Barré Syndrome Market Size and Growth Rate of Retail Pharmacies

      • 5.5.4 China Guillain-Barré Syndrome Market Size and Growth Rate of Hospital Pharmacies

    Chapter 6 China Guillain-Barré Syndrome Market, by Region

    • 6.1 China Guillain-Barré Syndrome Production Volume and Production Value, by Region

    • 6.2 China Guillain-Barré Syndrome Sales Volume and Sales Value, by Region

    Chapter 7 North China Guillain-Barré Syndrome Market Analysis

    • 7.1 North China Guillain-Barré Syndrome Market, by Type

    • 7.2 North China Guillain-Barré Syndrome Market, by Application

    Chapter 8 Central China Guillain-Barré Syndrome Market Analysis

    • 8.1 Central China Guillain-Barré Syndrome Market, by Type

    • 8.2 Central China Guillain-Barré Syndrome Market, by Application

    Chapter 9 South China Guillain-Barré Syndrome Market Analysis

    • 9.1 South China Guillain-Barré Syndrome Market, by Type

    • 9.2 South China Guillain-Barré Syndrome Market, by Application

    Chapter 10 East China Guillain-Barré Syndrome Market Analysis

    • 10.1 East China Guillain-Barré Syndrome Market, by Type

    • 10.2 East China Guillain-Barré Syndrome Market, by Application

    Chapter 11 Northeast China Guillain-Barré Syndrome Market Analysis

    • 11.1 Northeast China Guillain-Barré Syndrome Market, by Type

    • 11.2 Northeast China Guillain-Barré Syndrome Market, by Application

    Chapter 12 Southwest China Guillain-Barré Syndrome Market Analysis

    • 12.1 Southwest China Guillain-Barré Syndrome Market, by Type

    • 12.2 Southwest China Guillain-Barré Syndrome Market, by Application

    Chapter 13 Northwest China Guillain-Barré Syndrome Market Analysis

    • 13.1 Northwest China Guillain-Barré Syndrome Market, by Type

    • 13.2 Northwest China Guillain-Barré Syndrome Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Nihon Pharmaceutical

        • 14.1.1 Nihon Pharmaceutical Company Profile

        • 14.1.2 Nihon Pharmaceutical Guillain-Barré Syndrome Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Akari Therapeutics

        • 14.2.1 Akari Therapeutics Company Profile

        • 14.2.2 Akari Therapeutics Guillain-Barré Syndrome Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 CSL Behring

        • 14.3.1 CSL Behring Company Profile

        • 14.3.2 CSL Behring Guillain-Barré Syndrome Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Kedrion

        • 14.4.1 Kedrion Company Profile

        • 14.4.2 Kedrion Guillain-Barré Syndrome Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Biotest

        • 14.5.1 Biotest Company Profile

        • 14.5.2 Biotest Guillain-Barré Syndrome Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Grifols

        • 14.6.1 Grifols Company Profile

        • 14.6.2 Grifols Guillain-Barré Syndrome Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 China Biologic Products Holdings

        • 14.7.1 China Biologic Products Holdings Company Profile

        • 14.7.2 China Biologic Products Holdings Guillain-Barré Syndrome Market Performance

        • 14.7.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Guillain-Barré Syndrome Industry Research Conclusions

    • 15.2 Guillain-Barré Syndrome Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Guillain-Barré Syndrome Industry Market Size (2018-2029)

    • Figure China Guillain-Barré Syndrome Production Volume, Production Value and Growth Rate of LMWH (2018-2029)

    • Figure China Guillain-Barré Syndrome Production Volume, Production Value and Growth Rate of Plasma Exchange (2018-2029)

    • Figure China Guillain-Barré Syndrome Production Volume, Production Value and Growth Rate of Anticonvulsants (2018-2029)

    • Figure China Guillain-Barré Syndrome Production Volume, Production Value and Growth Rate of Analgesics (2018-2029)

    • Figure China Guillain-Barré Syndrome Production Volume, Production Value and Growth Rate of Intravenous Immunoglobulin (2018-2029)

    • Figure China Guillain-Barré Syndrome Sales Volume, Sales Value and Growth Rate of Home Care (2018-2029)

    • Figure China Guillain-Barré Syndrome Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

    • Figure China Guillain-Barré Syndrome Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)

    • Figure China Guillain-Barré Syndrome Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)

    • Figure North China Guillain-Barré Syndrome Market Size and Growth Rate from 2018-2029

    • Figure Central China Guillain-Barré Syndrome Market Size and Growth Rate from 2018-2029

    • Figure South China Guillain-Barré Syndrome Market Size and Growth Rate from 2018-2029

    • Figure East China Guillain-Barré Syndrome Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Guillain-Barré Syndrome Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Guillain-Barré Syndrome Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Guillain-Barré Syndrome Market Size and Growth Rate from 2018-2029

    • Figure Guillain-Barré Syndrome Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Guillain-Barré Syndrome Market Share by Type in 2018

    • Figure China Guillain-Barré Syndrome Market Share by Type in 2023

    • Figure China Guillain-Barré Syndrome Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Guillain-Barré Syndrome Production Volume and Growth Rate of LMWH (2018-2023)

    • Figure China Guillain-Barré Syndrome Production Volume and Growth Rate of Plasma Exchange (2018-2023)

    • Figure China Guillain-Barré Syndrome Production Volume and Growth Rate of Anticonvulsants (2018-2023)

    • Figure China Guillain-Barré Syndrome Production Volume and Growth Rate of Analgesics (2018-2023)

    • Figure China Guillain-Barré Syndrome Production Volume and Growth Rate of Intravenous Immunoglobulin (2018-2023)

    • Figure China Guillain-Barré Syndrome Market Share by Application in 2018

    • Figure China Guillain-Barré Syndrome Market Share by Application in 2023

    • Figure China Guillain-Barré Syndrome Total Market Size and Growth Rate from Consumption End

    • Figure China Guillain-Barré Syndrome Market Size and Growth Rate of Home Care (2018-2023)

    • Figure China Guillain-Barré Syndrome Market Size and Growth Rate of Clinics (2018-2023)

    • Figure China Guillain-Barré Syndrome Market Size and Growth Rate of Retail Pharmacies (2018-2023)

    • Figure China Guillain-Barré Syndrome Market Size and Growth Rate of Hospital Pharmacies (2018-2023)

    • Table China Guillain-Barré Syndrome Production Volume by Region (2018-2023)

    • Table China Guillain-Barré Syndrome Production Volume Share by Region (2018-2023)

    • Figure China Guillain-Barré Syndrome Production Volume Share by Region (2018-2023)

    • Table China Guillain-Barré Syndrome Production Value by Region (2018-2023)

    • Table China Guillain-Barré Syndrome Production Value Share by Region (2018-2023)

    • Figure China Guillain-Barré Syndrome Production Value Share by Region (2018-2023)

    • Table China Guillain-Barré Syndrome Sales Volume by Region (2018-2023)

    • Table China Guillain-Barré Syndrome Sales Volume Share by Region (2018-2023)

    • Figure China Guillain-Barré Syndrome Sales Volume Share by Region (2018-2023)

    • Table China Guillain-Barré Syndrome Sales Value by Region (2018-2023)

    • Table China Guillain-Barré Syndrome Sales Value Share by Region (2018-2023)

    • Figure China Guillain-Barré Syndrome Sales Value Share by Region (2018-2023)

    • Table North China Guillain-Barré Syndrome Production Volume by Type (2018-2023)

    • Table North China Guillain-Barré Syndrome Production Volume Share by Type (2018-2023)

    • Figure North China Guillain-Barré Syndrome Production Volume Share by Type (2018-2023)

    • Table North China Guillain-Barré Syndrome Sales Volume by Application (2018-2023)

    • Table North China Guillain-Barré Syndrome Sales Volume Share by Application (2018-2023)

    • Figure North China Guillain-Barré Syndrome Sales Volume Share by Application (2018-2023)

    • Table Central China Guillain-Barré Syndrome Production Volume by Type (2018-2023)

    • Table Central China Guillain-Barré Syndrome Production Volume Share by Type (2018-2023)

    • Figure Central China Guillain-Barré Syndrome Production Volume Share by Type (2018-2023)

    • Table Central China Guillain-Barré Syndrome Sales Volume by Application (2018-2023)

    • Table Central China Guillain-Barré Syndrome Sales Volume Share by Application (2018-2023)

    • Figure Central China Guillain-Barré Syndrome Sales Volume Share by Application (2018-2023)

    • Table South China Guillain-Barré Syndrome Production Volume by Type (2018-2023)

    • Table South China Guillain-Barré Syndrome Production Volume Share by Type (2018-2023)

    • Figure South China Guillain-Barré Syndrome Production Volume Share by Type (2018-2023)

    • Table South China Guillain-Barré Syndrome Sales Volume by Application (2018-2023)

    • Table South China Guillain-Barré Syndrome Sales Volume Share by Application (2018-2023)

    • Figure South China Guillain-Barré Syndrome Sales Volume Share by Application (2018-2023)

    • Table East China Guillain-Barré Syndrome Production Volume by Type (2018-2023)

    • Table East China Guillain-Barré Syndrome Production Volume Share by Type (2018-2023)

    • Figure East China Guillain-Barré Syndrome Production Volume Share by Type (2018-2023)

    • Table East China Guillain-Barré Syndrome Sales Volume by Application (2018-2023)

    • Table East China Guillain-Barré Syndrome Sales Volume Share by Application (2018-2023)

    • Figure East China Guillain-Barré Syndrome Sales Volume Share by Application (2018-2023)

    • Table Northeast China Guillain-Barré Syndrome Production Volume by Type (2018-2023)

    • Table Northeast China Guillain-Barré Syndrome Production Volume Share by Type (2018-2023)

    • Figure Northeast China Guillain-Barré Syndrome Production Volume Share by Type (2018-2023)

    • Table Northeast China Guillain-Barré Syndrome Sales Volume by Application (2018-2023)

    • Table Northeast China Guillain-Barré Syndrome Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Guillain-Barré Syndrome Sales Volume Share by Application (2018-2023)

    • Table Southwest China Guillain-Barré Syndrome Production Volume by Type (2018-2023)

    • Table Southwest China Guillain-Barré Syndrome Production Volume Share by Type (2018-2023)

    • Figure Southwest China Guillain-Barré Syndrome Production Volume Share by Type (2018-2023)

    • Table Southwest China Guillain-Barré Syndrome Sales Volume by Application (2018-2023)

    • Table Southwest China Guillain-Barré Syndrome Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Guillain-Barré Syndrome Sales Volume Share by Application (2018-2023)

    • Table Northwest China Guillain-Barré Syndrome Production Volume by Type (2018-2023)

    • Table Northwest China Guillain-Barré Syndrome Production Volume Share by Type (2018-2023)

    • Figure Northwest China Guillain-Barré Syndrome Production Volume Share by Type (2018-2023)

    • Table Northwest China Guillain-Barré Syndrome Sales Volume by Application (2018-2023)

    • Table Northwest China Guillain-Barré Syndrome Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Guillain-Barré Syndrome Sales Volume Share by Application (2018-2023)

    • Table Nihon Pharmaceutical Company Profile

    • Table Nihon Pharmaceutical Guillain-Barré Syndrome Revenue, Price and Gross (2018-2023)

    • Table Akari Therapeutics Company Profile

    • Table Akari Therapeutics Guillain-Barré Syndrome Revenue, Price and Gross (2018-2023)

    • Table CSL Behring Company Profile

    • Table CSL Behring Guillain-Barré Syndrome Revenue, Price and Gross (2018-2023)

    • Table Kedrion Company Profile

    • Table Kedrion Guillain-Barré Syndrome Revenue, Price and Gross (2018-2023)

    • Table Biotest Company Profile

    • Table Biotest Guillain-Barré Syndrome Revenue, Price and Gross (2018-2023)

    • Table Grifols Company Profile

    • Table Grifols Guillain-Barré Syndrome Revenue, Price and Gross (2018-2023)

    • Table China Biologic Products Holdings Company Profile

    • Table China Biologic Products Holdings Guillain-Barré Syndrome Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.